全文获取类型
收费全文 | 3782篇 |
免费 | 216篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 60篇 |
儿科学 | 123篇 |
妇产科学 | 81篇 |
基础医学 | 507篇 |
口腔科学 | 74篇 |
临床医学 | 350篇 |
内科学 | 758篇 |
皮肤病学 | 50篇 |
神经病学 | 508篇 |
特种医学 | 211篇 |
外科学 | 449篇 |
综合类 | 18篇 |
一般理论 | 3篇 |
预防医学 | 236篇 |
眼科学 | 40篇 |
药学 | 321篇 |
中国医学 | 6篇 |
肿瘤学 | 212篇 |
出版年
2023年 | 20篇 |
2022年 | 34篇 |
2021年 | 87篇 |
2020年 | 55篇 |
2019年 | 93篇 |
2018年 | 82篇 |
2017年 | 64篇 |
2016年 | 92篇 |
2015年 | 112篇 |
2014年 | 130篇 |
2013年 | 157篇 |
2012年 | 273篇 |
2011年 | 303篇 |
2010年 | 202篇 |
2009年 | 169篇 |
2008年 | 275篇 |
2007年 | 297篇 |
2006年 | 282篇 |
2005年 | 288篇 |
2004年 | 216篇 |
2003年 | 196篇 |
2002年 | 217篇 |
2001年 | 31篇 |
2000年 | 27篇 |
1999年 | 40篇 |
1998年 | 34篇 |
1997年 | 36篇 |
1996年 | 26篇 |
1995年 | 20篇 |
1994年 | 23篇 |
1993年 | 16篇 |
1992年 | 9篇 |
1991年 | 8篇 |
1990年 | 6篇 |
1989年 | 8篇 |
1988年 | 3篇 |
1987年 | 3篇 |
1985年 | 4篇 |
1984年 | 6篇 |
1983年 | 3篇 |
1982年 | 7篇 |
1981年 | 6篇 |
1979年 | 3篇 |
1974年 | 3篇 |
1970年 | 3篇 |
1967年 | 2篇 |
1961年 | 3篇 |
1960年 | 3篇 |
1914年 | 2篇 |
1908年 | 3篇 |
排序方式: 共有4007条查询结果,搜索用时 15 毫秒
91.
92.
93.
94.
OBJECTIVES AND DESIGN: To check whether antihypertensive effects are additive or synergistic upon blockade of both angiotensin (AT1)-receptors and angiotensin-converting enzyme (ACE), spontaneously hypertensive rats (SHR) were treated with candesartan-cilexetil (0.1-30 mg/kg per day), ramipril (0.03-10 mg/kg per day), the calcium-antagonist mibefradil (1-150 mg/kg per day) or combinations thereof. Systolic blood pressure (SBP), left ventricular weight (LVW) and the cardiac activity/mRNA levels of ACE were determined. RESULTS: SBP was decreased by candesartan-cilexetil [inhibitory concentration (IC50) (mg/kg): 2.47], ramipril (1.97), mibefradil (4.41), candesartan-cilexetil/ramipril (0.68), and candesartan-cilexetil/mibefradil (5.68). Combining candesartan-cilexetil with ramipril increased SBP reduction synergistically rather than additively, since the dose-response curve was shifted 6.6-fold leftwards compared to a hypothetically generated additive curve, calculated by summing up the doses and corresponding effects of the ramipril and candesartan-cilexetil monotreatment regimes. A total threshold dose < 5.14 mg/kg (derived from dose-response curves) was found to exert synergistic effects when candesartan-cilexetil was combined with ramipril. Antihypertensive effects of mibefradil can not be increased when combined with candesartan-cilexetil. When LVW was correlated with SBP reduction, regression lines of candesartan-cilexetil, ramipril and their combination were congruent, while that for mibefradil was significantly flatter and became steeper under candesartan-cilexetil co-administration. Cardiac ACE activity was greatly reduced by ramipril independently of SBP reduction and dosage. With SBP-ineffective doses of ramipril, cardiac ACE mRNA levels were doubled, indicating a positive feedback mechanism. The increase in ACE mRNA was renormalized when SPB-effective ramipril doses were applied, suggesting a blood pressure-dependent regulation of cardiac ACE expression. CONCLUSIONS: Since synergy was observed only after combining low doses of ramipril and candesartan-cilexetil, prospective clinical trials should be performed on a low-dose combination, revealing the antihypertensive/antiproliferative benefits. 相似文献
95.
96.
Radiographic Monitoring of Changes in Bone Height after Implant Placement in Combination with an Internal Sinus Lift without Graft Material
下载免费PDF全文
![点击此处可从《Clinical implant dentistry and related research》网站下载免费的PDF全文](/ch/ext_images/free.gif)
97.
Trauma und Berufskrankheit - Zum 01.01.2013 sind in der gesetzlichen Unfallversicherung die neuen Anforderungen an Krankenhäuser für die Beteiligung am stationären... 相似文献
98.
ADAMTSL4‐associated isolated ectopia lentis: Further patients,novel mutations and a detailed phenotype description
下载免费PDF全文
![点击此处可从《American journal of medical genetics. Part A》网站下载免费的PDF全文](/ch/ext_images/free.gif)
99.
Mitochondria organize themselves as dynamic populations within a cell, by undergoing continuous cycles of fission and fusion. The spatio-temporal distribution and abundance of mitochondria determines the cell’s energy budget and is thus intimately linked to the cell’s response to environmental stimuli during aging. The dynamic balance of mitochondrial fission and fusion can be studied in terms of antagonistic subpopulations that regulate the mitochondrial responses in space and time. The dynamic nature of these processes motivates mathematical modelling and the simulation of such complex process. In several neurodegenerative and metabolic diseases the dynamic balance of fission and fusion is disturbed. However, how this dynamics plays a role in the progression of diseases is largely unclear. Fission and fusion help mitochondria to regulate cellular energy (ATP) levels, and minimize accumulation of harmful oxidized material called reactive oxygen species which accelerate mutations in mitochondrial DNA (mtDNA) during aging. We discuss how systems biology approaches can be used to investigate the mechanisms controlling the fission–fusion dynamics under two categories: dissecting the design of its molecular regulatory motifs, and understanding complex mitochondrial responses through their population level interactions. This will help us to understand how different regulatory mechanisms regulate the ATP and mutation (mtDNA) landscape of mitochondria to a variety of environmental stimuli in order to maintain their function during aging. 相似文献
100.
Maria Benito de Valle Tobias Müller Einar Björnsson Morgane Otten Martin Volkmann Olaf Guckelberger Bertram Wiedenmann Riadh Sadik Eckart Schott Mats Andersson Thomas Berg Björn Lindkvist 《Digestive and liver disease》2014,46(10):903-908